Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ACTRN12625001420437) titled 'Efficacy of Tight Versus Moderate Glycemic Control on the Rate of Surgical Site Infection in Patients with Diabetes Mellitus Undergoing Coronary Artery Bypass Graft (CABG) -A Single Centre Prospective Randomized Control Trial' on Dec. 17, 2025.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used) Assignment: Parallel Type of endpoint: Efficacy

Primary Sponsor: Sarawak Consolidated Industries

Condition: Heart Surgery Surgical Site Infection Diabetes Mellitus Type 2 Heart Surgery Surgical Site Infection Diabetes Mellitus Type 2...